Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Oncology

Can You Get Preventative Stomach Removal After 40?

At a Glance

Yes, you can still undergo a preventative stomach removal (prophylactic total gastrectomy) for a CDH1 mutation after age 40. While guidelines often emphasize early adulthood to remove the stomach before cancer develops, healthy older adults regularly choose this surgery to eliminate their risk.

In this answer

3 sections

01

Why Guidelines Emphasize Early Adulthood

02

Balancing Risks Later in Life

03

What Are the Alternatives?

Yes, you can absolutely still choose to have a prophylactic total gastrectomy (PTG) to prevent hereditary diffuse gastric cancer (HDGC) if you are over 40. While you may read clinical guidelines that highlight early adulthood (typically your 20s or 30s) as the optimal window to eliminate cancer risk before it typically starts, this does not mean the door closes later in life [1][2]. Many people who are diagnosed with a CDH1 mutation (a genetic change that increases cancer risk) in their 40s, 50s, or beyond successfully undergo this preventative surgery [3][4]. The conversation simply shifts toward personalizing the decision based on your current health, recovery ability, and your family’s specific cancer history. There is no need to panic—you have time to get multiple opinions, assemble a care team, and carefully weigh your options.

Why Guidelines Emphasize Early Adulthood

Because diffuse gastric cancer often develops early in life for CDH1 mutation carriers, doctors recommend preventative surgery in early adulthood to maximize the cancer-preventing benefits [1][2][5]. This age range is emphasized not because the surgery becomes impossible or ineffective later in life, but rather to remove the stomach before microscopic cancer cells have a chance to grow.

Regular stomach screening with an endoscopy (a procedure where a flexible tube with a camera is used to look inside the stomach) often misses these early, microscopic cancer cells [6][7][5]. Because screening is not foolproof, completely removing the stomach remains the most reliable way to eliminate the risk of developing diffuse gastric cancer, regardless of your age [6][7][8].

Balancing Risks Later in Life

When deciding on a total gastrectomy in your 50s or beyond, you and your medical team will carefully weigh the benefits of cancer prevention against the physical impact of the procedure. Clinical management of HDGC is highly individualized, taking into account the following factors [2][9][10]:

  • Lifetime Cancer Risk: The cumulative lifetime risk of developing diffuse gastric cancer for CDH1 mutation carriers remains very high—often estimated between 60% and 80% by age 80, though some recent studies suggest it may be lower in certain families [8][11][12]. Removing your stomach entirely eliminates your risk of gastric cancer, though you will still need regular screening for other CDH1-related risks, such as lobular breast cancer in women [13][14].
  • Surgical and Recovery Risks: A total gastrectomy is a major operation. While age alone does not disqualify you from surgery—many otherwise healthy individuals in their 50s and 60s safely undergo the procedure—conditions that become more common as we age, like heart disease, lung issues, or diabetes, can make recovery more difficult [15][16]. Your surgical team will thoroughly assess your overall fitness to ensure your body can safely handle the operation and the healing process [15][16].
  • Quality of Life: Living without a stomach requires lifelong adjustments. For example, you will need to eat very small, frequent meals rather than three large ones, and you will likely require lifelong vitamin B12 injections since the stomach normally absorbs this nutrient [8][3][17]. You will need to weigh the peace of mind that comes from preventing cancer against these permanent dietary changes. Additionally, for many patients, avoiding the psychological toll and anxiety of undergoing frequent, invasive endoscopies (often called “scanxiety”) is a major factor in choosing surgery [18][19].

What Are the Alternatives?

If you and your doctor decide that surgery is not the right fit right now—or if you choose to delay it while preparing—the primary alternative is enhanced endoscopic surveillance [2][20]. This involves using specialized, intensive protocols (like the Cambridge protocol, which requires taking dozens of random biopsies throughout the stomach) every 6 to 12 months to carefully monitor for early signs of cancer [21][22][5]. However, it is important to remember that this method is not perfect and can still miss early-stage cancer cells [6][4][23]. Ultimately, the decision between surgery and surveillance is a deeply personal one that you will make alongside a specialized medical team.

Common questions in this guide

Can I get a prophylactic total gastrectomy if I'm over 40?
Yes, many people in their 40s, 50s, and older safely undergo preventative stomach removal. The decision is based on your overall health, ability to recover, and specific family cancer history, rather than a strict age limit.
Why do doctors usually recommend stomach removal in your 20s or 30s?
Doctors typically recommend surgery in early adulthood because diffuse gastric cancer often develops early in life for CDH1 mutation carriers. The goal is to remove the stomach proactively before any microscopic cancer cells have a chance to begin growing.
What are the risks of having preventative stomach removal later in life?
While age itself doesn't disqualify you, older adults are more likely to have other health conditions like heart disease or diabetes. These underlying conditions can make recovery from a major operation like a total gastrectomy more challenging.
What is the alternative to having my stomach removed?
If you delay or decline surgery, the primary alternative is enhanced endoscopic surveillance. This involves undergoing an endoscopy every 6 to 12 months with dozens of random biopsies to monitor the stomach, though it can still miss microscopic cancer cells.
How will my daily life change after having a total gastrectomy?
Living without a stomach requires permanent lifestyle and dietary adjustments. You will need to eat very small, frequent meals instead of standard-sized meals, and you will require lifelong vitamin B12 injections since your body will no longer absorb it naturally.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my age and overall health profile, what are my personal surgical risks for a prophylactic total gastrectomy?
  2. 2.How many preventative stomach removal surgeries have you performed on patients over 40, and what has their recovery looked like?
  3. 3.Based on my family's specific history of HDGC, what is the best estimate of my current and future cancer risk?
  4. 4.If I choose to pursue surgery, what is a safe timeline for me to prepare, get second opinions, and schedule the procedure?
  5. 5.If I choose surveillance instead, what specific endoscopy protocol will we use and how frequently will it happen?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

How to Absorb B12 and Iron After Total GastrectomyWhy Test for H. pylori if HDGC Gastric Cancer is Genetic?CDH1 & Colon Cancer: What Are the Screening Guidelines?Gastrectomy Dumping Syndrome: Symptoms & CareWhat Connects Cleft Lip and CDH1 Stomach Cancer?Total Gastrectomy Recovery: When Can I Return to Work?CTNNA1 Mutation: Stomach Cancer Risk & Surgery OptionsIncidental CDH1 Mutation: What Is My Stomach Cancer Risk?What to Ask a Surgeon Before HDGC Total Gastrectomy?What Breast Cancer Does CDH1 Cause? Risk & MRI Guidelines

References

References (23)
  1. 1

    Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer.

    Shepard B, Yoder L, Holmes C

    ACG case reports journal 2016; (3(4)):e179 doi:10.14309/crj.2016.152.

    PMID: 28008412
  2. 2

    Hereditary diffuse gastric cancer: updated clinical practice guidelines.

    Blair VR, McLeod M, Carneiro F, et al.

    The Lancet. Oncology 2020; (21(8)):e386-e397 doi:10.1016/S1470-2045(20)30219-9.

    PMID: 32758476
  3. 3

    Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.

    DiBrito SR, Blair AB, Prasath V, et al.

    The Journal of surgical research 2020; (247()):438-444 doi:10.1016/j.jss.2019.09.062.

    PMID: 31685251
  4. 4

    Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.

    Strong VE, Gholami S, Shah MA, et al.

    Annals of surgery 2017; (266(6)):1006-1012 doi:10.1097/SLA.0000000000002030.

    PMID: 27759617
  5. 5

    Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations.

    Kumar S, Katona BW, Long JM, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020; (18(2)):505-508.e1 doi:10.1016/j.cgh.2019.04.064.

    PMID: 31077828
  6. 6

    Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers.

    Ithurralde-Argerich J, Rosner L, Rizzolo M, et al.

    Journal of laparoendoscopic & advanced surgical techniques. Part A 2021; (31(7)):729-737 doi:10.1089/lap.2021.0239.

    PMID: 34097461
  7. 7

    Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients.

    Hüneburg R, Marwitz T, van Heteren P, et al.

    Endoscopy international open 2016; (4(12)):E1305-E1310 doi:10.1055/s-0042-112582.

    PMID: 27995193
  8. 8

    Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.

    van der Kaaij RT, van Kessel JP, van Dieren JM, et al.

    The British journal of surgery 2018; (105(2)):e176-e182 doi:10.1002/bjs.10754.

    PMID: 29341148
  9. 9

    Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.

    van der Sluis L, van Dieren JM, van der Post RS, Bisseling TM

    Hereditary cancer in clinical practice 2024; (22(1)):21 doi:10.1186/s13053-024-00293-5.

    PMID: 39379994
  10. 10

    Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer.

    Lerner BA, Gupta S, Burke CA, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2025; (23(4)).

    PMID: 40203872
  11. 11

    Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch?

    Leclercq P, Jadot V, Bours V, et al.

    Therapeutic advances in gastroenterology 2020; (13()):1756284820916399 doi:10.1177/1756284820916399.

    PMID: 32523621
  12. 12

    Germline CDH1 Variants and Lifetime Cancer Risk.

    Ryan CE, Fasaye GA, Gallanis AF, et al.

    JAMA 2024; (332(9)):722-729 doi:10.1001/jama.2024.10852.

    PMID: 38873722
  13. 13

    Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer.

    Mokhtari-Esbuie F, Szeglin B, Ravari MR, et al.

    eGastroenterology 2023; (1(2)) doi:10.1136/egastro-2023-100017.

    PMID: 38188186
  14. 14

    CDH1 mutations in gastric cancer patients from northern Brazil identified by Next- Generation Sequencing (NGS).

    El-Husny A, Raiol-Moraes M, Amador M, et al.

    Genetics and molecular biology 2016; (39(2)):189-98.

    PMID: 27192129
  15. 15

    Factors influencing postoperative complications in patients with gastric cancer: A retrospective study.

    Xiao Y, Ren BC, Zhang T, et al.

    World journal of gastrointestinal surgery 2025; (17(5)):101047 doi:10.4240/wjgs.v17.i5.101047.

    PMID: 40502486
  16. 16

    Risk factors associated with postoperative morbidity and mortality in D2 radical gastrectomy for gastric cancer.

    Paredes-Torres OR, García-Ruiz L, Luna-Abanto J, et al.

    Revista de gastroenterologia de Mexico (English) 2022; (87(2)):149-158 doi:10.1016/j.rgmxen.2021.07.003.

    PMID: 34362678
  17. 17

    Emerging Adults Carrying a CDH1 Pathogenic or Likely Pathogenic Variant Face Diet and Lifestyle Challenges after Total Gastrectomy.

    Liu Y, Lopez R

    Journal of the Academy of Nutrition and Dietetics 2022; (122(5)):913-917 doi:10.1016/j.jand.2021.12.012.

    PMID: 34968751
  18. 18

    The Psychological Impact of Prophylactic Total Gastrectomy in Patients Who Are High Risk for Hereditary Diffuse Gastric Cancer: A Review of the Literature.

    Hayat MY, Yakubu U, Jayasinghe J, Patel B

    Cureus 2025; (17(5)):e84751 doi:10.7759/cureus.84751.

    PMID: 40551901
  19. 19

    Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy.

    Gamble LA, Grant RRC, Samaranayake SG, et al.

    Journal of medical genetics 2023; (60(3)):241-246 doi:10.1136/jmg-2022-108733.

    PMID: 35817563
  20. 20

    [Hereditary gastric cancer syndromes and their association with specific histological subtypes].

    Dardenne A, Sirmai L, Metras J, et al.

    Bulletin du cancer 2023; (110(5)):512-520 doi:10.1016/j.bulcan.2022.06.010.

    PMID: 35963792
  21. 21

    Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.

    Asif B, Sarvestani AL, Gamble LA, et al.

    The Lancet. Oncology 2023; (24(4)):383-391 doi:10.1016/S1470-2045(23)00057-8.

    PMID: 36990610
  22. 22

    Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1.

    Mejia Perez LK, O'Malley M, Chatterjee A, et al.

    Familial cancer 2024; (23(4)):617-626 doi:10.1007/s10689-024-00421-z.

    PMID: 39261344
  23. 23

    Random biopsies in patients harboring a CDH1 mutation: time to change the approach?

    Castro R, Lobo J, Pita I, et al.

    Revista espanola de enfermedades digestivas 2020; (112(5)):367-372 doi:10.17235/reed.2020.6720/2019.

    PMID: 32338015

This page provides educational information about preventative stomach removal for HDGC. Always consult with your surgical and genetic oncology team to determine if surgery is appropriate for your specific age and health profile.

Get notified when new evidence is published on Hereditary diffuse gastric cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.